Assembly Biosciences, Inc. ASMB
19.99 USD +0.07 (+0.35%)
Nov 4, 2026, 1:06 PM EST
19.64 Day range 20.54
19.25 52-week range 39.71
- YTD
- -41.22%
- 1 year
- -36.40%
Analyst view
Price target (mean) 35.50 +77.6% upside
Now 19.99
- Target (low)
- 35.00
- Target (mean)
- 35.50
- Target (high)
- 36.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.75 | -1.75 – -1.75 | -1.74 | -0.6% | 7.05M | -1.6% | 1 |
| Next quarter | -1.95 | -1.95 – -1.95 | -1.66 | -17.5% | 7.97M | 0.0% | 1 |
| Current year | -6.87 | -6.87 – -6.87 | -13.38 | +48.7% | 28.21M | +293.9% | 1 |
| Next year | -8.03 | -8.03 – -8.03 | -6.87 | -16.9% | 33.15M | +17.5% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 20, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Jun 13, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Apr 1, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |